| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:76-83.)
© 2005 American Heart Association, Inc.
Molecular Cardiology |
From the Department of Molecular Medicine (J.H., K.N., Y.I., S.H., K.T., T.T., Y.M., K.I., K.K., H.H.), the Division of Gene Therapy (Y.I., H.H.), and the Department of Thoracic and Cardiovascular Surgery (T.U., M.M.), Sapporo Medical University, Sapporo, Japan.
Correspondence to Hirofumi Hamada, MD, PhD, Department of Molecular Medicine, Sapporo Medical University, South 1, West 17, Chuo-ku, Sapporo, 060-8556, Japan. E-mail hhamada{at}sapmed.ac.jp
Received June 27, 2004; de novo received January 12, 2005; revision received February 25, 2005; accepted March 8, 2005.
Background Apoptosis is an important cause of early graft loss after heart transplantation. Bcl-xL was reported to protect the heart against normothermic ischemia and reperfusion injury. In this study, we determined whether overexpression of Bcl-xL could inhibit tissue injury resulting from prolonged cold preservation followed by warm reperfusion of heart transplants.
Methods and Results Lewis rat hearts were transduced with an adenovirus vector harboring Bcl-xL cDNA (AxCAhBclxL) 4 days before collection of tissue. After preservation in University of Wisconsin solution at 4°C for 24 hours, the heart was either perfused with a Langendorff device ex vivo or used for heterotopic heart transplantation in vivo. Bcl-xL gene transfer significantly reduced the infarct size (23.0±2.6% versus 47.7±7.0% in saline control and 48.6±6.1% in vector control, P<0.01) after 2-hour reperfusion at 37°C with the Langendorff device and significantly decreased creatine kinase release (0.82±0.27 IU, versus 1.57±0.33 and 1.50±0.37 IU in saline and vector controls, respectively; P<0.05). In heart transplantation, overexpresson of Bcl-xL inhibited Bax translocation from the cytosol to the mitochondria, resulting in decreased cytochrome c release from the mitochondria; it also significantly decreased cardiac cell apoptosis and improved graft survival rate after long cold preservation, followed by warm reperfusion.
Conclusions Bcl-xL gene transfer inhibited the translocation of Bax and prolonged the cold preservation time of cardiac transplants. This may be a potential therapeutic method in clinical practice.
Key Words: gene therapy ischemia reperfusion transplantation apoptosis
Related Article:
Circulation 2005 112: 6-8.
This article has been cited by other articles:
![]() |
A. Havasi, Z. Li, Z. Wang, J. L. Martin, V. Botla, K. Ruchalski, J. H. Schwartz, and S. C. Borkan Hsp27 Inhibits Bax Activation and Apoptosis via a Phosphatidylinositol 3-Kinase-dependent Mechanism J. Biol. Chem., May 2, 2008; 283(18): 12305 - 12313. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-L. Yue, S. S. Nerurkar, W. Bao, B. M. Jucker, L. Sarov-Blat, K. Steplewski, E. H. Ohlstein, and R. N. Willette In Vivo Activation of Peroxisome Proliferator-Activated Receptor-{delta} Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gustafsson and R. A. Gottlieb Heart mitochondria: gates of life and death Cardiovasc Res, January 15, 2008; 77(2): 334 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamacher-Brady, N. R. Brady, and R. A. Gottlieb Enhancing Macroautophagy Protects against Ischemia/Reperfusion Injury in Cardiac Myocytes J. Biol. Chem., October 6, 2006; 281(40): 29776 - 29787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schaper and S. Kostin Cell Death and Adenosine Triphosphate: The Paradox Circulation, July 5, 2005; 112(1): 6 - 8. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |